Securities Code: 002393 Securities Abbreviation: Life Pharmaceutical Announcement No.: 2026-031
Tianjin Life Pharmaceutical Co., Ltd. Announcement on Pre-disclosure of Share Reduction Plan by Senior Management
The senior management member of this company, Ms. Guo Xiaoyan, guarantees that the information provided to this company is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions. This company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor.
Special Reminder: Ms. Guo Xiaoyan, a senior management member of Tianjin Life Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company"), holding 124,320 shares (accounting for 0.0402% of the Company's total share capital; accounting for 0.0403% of the Company's total share capital after excluding shares in the repurchase account), plans to reduce her holdings by centralized bidding within 3 months after 15 trading days from the date of this announcement, with a total reduction not exceeding 22,042 shares, representing no more than 0.0072% of the Company's total share capital after excluding shares in the repurchase account.
The Company has recently received the "Application for Share Reduction Plan" from senior management member Ms. Guo Xiaoyan, and the specific content is hereby announced as follows:
I. Basic Information of the Shareholder Intending to Reduce Holdings